Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.38
-0.27 (-2.32%)
At close: Jul 8, 2026, 4:00 PM EDT
11.44
+0.06 (0.53%)
After-hours: Jul 8, 2026, 5:00 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $225.23 million as of July 8, 2026. Its market cap has decreased by -59.70% in one year.
Market Cap
225.23M
Enterprise Value
-34.22M
1-Year Change
-59.70%
Ranking
Category
Stock Price
$11.38
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $225.23M, a decrease of -41.55%. That is a compound annual growth rate of -8.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 225.23M | -63.69% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 237.13M |
| Codexis | 236.33M |
| ProQR Therapeutics | 234.26M |
| NovaBridge Biosciences | 233.61M |
| Q32 Bio | 230.95M |
| Camp4 Therapeutics | 228.47M |
| Voyager Therapeutics | 228.39M |
| Karyopharm Therapeutics | 227.76M |